Guangzhou Gloria Biosciences Co., Ltd.
Clinical trials sponsored by Guangzhou Gloria Biosciences Co., Ltd., explained in plain language.
-
Can an immunotherapy boost give advanced cervical cancer patients more time?
Disease control Recruiting nowResearchers are testing whether adding an experimental immunotherapy drug called GLS-010 to standard platinum-based chemotherapy, with or without bevacizumab, helps women with persistent, recurrent, or metastatic cervical cancer live longer. The trial enrolls about 424 women aged…
Phase 3 • Sponsor: Guangzhou Gloria Biosciences Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo may boost stem cell harvest for myeloma patients
Disease control Recruiting nowThis study tests whether adding motixafortide to standard G-CSF helps collect more stem cells for a bone marrow transplant in people with multiple myeloma. About 60 Chinese adults with active myeloma will receive either the drug combo or a placebo before stem cell collection. The…
Phase 3 • Sponsor: Guangzhou Gloria Biosciences Co., Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC